Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Therapeutic Solutions International

Therapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress Syndrome
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Announces Plans to Initiate Breast Cancer Clinical Trial Using FloraStilbene™ Immune Stimulator Through Res Nova Bio Subsidiary
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Spin Off Res Nova Bio Announces Recruitment of President and Chief Executive Officer
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Announces Improvements in Autism, Amyotrophic Lateral Sclerosis and Schizophrenia Cases Treated by Veltmeyer Institute for Advanced Therapeutics
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions Announces Universal Donor Myeloid Derived Suppressor Therapy Platform for Treatment of Chronic Obstructive Pulmonary Disease (COPD)
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc. to Provide Breast Cancer Patients Access to Novel Cancer Immunotherapy
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Announces Launch of Cancer Immunotherapy Spin-Off Res Nova Bio, Inc.
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Granted Landmark United States Patent on Ability of QuadraMune® Nutraceutical to Repair Injured Brains
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Develops Post JadiCell Maintenance Therapy for Chronic Obstructive Pulmonary Disease (COPD)
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Creates Disease Specific Therapeutic Platform Based on Gene Editing/Engineering of Inducible Pluripotent Stem Cells
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Receives IND Number 28508 for Chronic Obstructive Pulmonary Disease Clinical Trial and Enters Binding Discussions with FDA for Initiation of Phase I/II Clinical Trial
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Phase III Lung Adult Stem Cell Company Announces and Files Patent on Leukine-Induced Myeloid Derived Suppressor Cells and JadiCell™ for Treatment of COPD
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug
From Therapeutic Solutions International
Via Business Wire
Tickers OTC TSOI
Therapeutic Solutions International Provides Correction Re Prior Release
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell™ Universal Donor Adult Stem Cell Product
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Therapeutic Solutions International Announces Reduction of COVID-19 Associated Cognitive Decline by QuadraMune® Nutraceutical in Animal Model
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Therapeutic Solutions International Reports Positive Clinical Data on QuadraMune® Reduction of SARS-CoV-2 Spike Protein Induced Inflammation
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment
From Therapeutic Solutions International
Via Business Wire
Tickers OTC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.